• Je něco špatně v tomto záznamu ?

7H-dibenzo[c,g]carbazole and 5,9-dimethyldibenzo[c,g]carbazole exert multiple toxic events contributing to tumor promotion in rat liver epithelial 'stem-like' cells

Vondrácek J, Svihálková-Sindlerová L, Pencíková K, Krcmár P, Andrysík Z, Chramostová K, Marvanová S, Valovicová Z, Kozubík A, Gábelová A, Machala M.

. 2006 ; 596 (1-2) : 43-56.

Jazyk angličtina Země Nizozemsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07522884

Immature liver progenitor cells have been suggested to be an important target of hepatotoxins and hepatocarcinogens. The goal of the present study was to assess the impact of 7H-dibenzo[c,g]carbazole (DBC) and its tissue-specific carcinogenic N-methyl (N-MeDBC) and 5,9-dimethyl (DiMeDBC) derivatives on rat liver epithelial WB-F344 cells, in vitro model of liver progenitor cells. We investigated the cellular events associated with both tumor initiation and promotion, such as activation of aryl hydrocarbon receptor (AhR), changes in expression of enzymes involved in metabolic activation of DBC and its derivatives, effects on cell cycle, cell proliferation/apoptosis and inhibition of gap junctional intercellular communication (GJIC). N-MeDBC, a tissue-specific sarcomagen, was only a weak inhibitor of GJIC or inducer of AhR-mediated activity, and it did not affect either cell proliferation or apoptosis. DBC was efficient GJIC inhibitor, while DiMeDBC manifested the strongest AhR inducing activity. Accordingly, DiMeDBC was also the most potent inducer of cytochrome P450 1A1 (CYP1A1) and CYP1A2 expression among the three compounds tested. Both DBC and DiMeDBC induced expression of CYP1B1 and aldo-keto reductase 1C9 (AKR1C9). N-MeDBC failed to significantly upregulate CYP1A1/2 and it only moderately increased CYP1B1 or AKR1C9. Only the potent liver carcinogens, DBC and DiMeDBC, caused a significant increase of p53 phosphorylation at Ser15, an increased accumulation of cells in S-phase and apoptosis at micromolar concentrations. In addition, DiMeDBC was found to stimulate cell proliferation of contact-inhibited WB-F344 cells at 1 microM concentration, which is a mode of action that might further contribute to its hepatocarcinogenicity. The present data seem to suggest that the AhR activation, induction of enzymes involved in metabolic activation, inhibition of GJIC or stimulation of cell proliferation might all contribute to the hepatocarcinogenic effects of DBC and DiMeDBC.

000      
00000naa 2200000 a 4500
001      
bmc07522884
003      
CZ-PrNML
005      
20111210134555.0
008      
090511s2006 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Vondráček, Jan, $d 1970- $7 xx0137878
245    10
$a 7H-dibenzo[c,g]carbazole and 5,9-dimethyldibenzo[c,g]carbazole exert multiple toxic events contributing to tumor promotion in rat liver epithelial 'stem-like' cells / $c Vondrácek J, Svihálková-Sindlerová L, Pencíková K, Krcmár P, Andrysík Z, Chramostová K, Marvanová S, Valovicová Z, Kozubík A, Gábelová A, Machala M.
314    __
$a Laboratory of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Královopolská 135, 612 65 Brno, Czech Republic
520    9_
$a Immature liver progenitor cells have been suggested to be an important target of hepatotoxins and hepatocarcinogens. The goal of the present study was to assess the impact of 7H-dibenzo[c,g]carbazole (DBC) and its tissue-specific carcinogenic N-methyl (N-MeDBC) and 5,9-dimethyl (DiMeDBC) derivatives on rat liver epithelial WB-F344 cells, in vitro model of liver progenitor cells. We investigated the cellular events associated with both tumor initiation and promotion, such as activation of aryl hydrocarbon receptor (AhR), changes in expression of enzymes involved in metabolic activation of DBC and its derivatives, effects on cell cycle, cell proliferation/apoptosis and inhibition of gap junctional intercellular communication (GJIC). N-MeDBC, a tissue-specific sarcomagen, was only a weak inhibitor of GJIC or inducer of AhR-mediated activity, and it did not affect either cell proliferation or apoptosis. DBC was efficient GJIC inhibitor, while DiMeDBC manifested the strongest AhR inducing activity. Accordingly, DiMeDBC was also the most potent inducer of cytochrome P450 1A1 (CYP1A1) and CYP1A2 expression among the three compounds tested. Both DBC and DiMeDBC induced expression of CYP1B1 and aldo-keto reductase 1C9 (AKR1C9). N-MeDBC failed to significantly upregulate CYP1A1/2 and it only moderately increased CYP1B1 or AKR1C9. Only the potent liver carcinogens, DBC and DiMeDBC, caused a significant increase of p53 phosphorylation at Ser15, an increased accumulation of cells in S-phase and apoptosis at micromolar concentrations. In addition, DiMeDBC was found to stimulate cell proliferation of contact-inhibited WB-F344 cells at 1 microM concentration, which is a mode of action that might further contribute to its hepatocarcinogenicity. The present data seem to suggest that the AhR activation, induction of enzymes involved in metabolic activation, inhibition of GJIC or stimulation of cell proliferation might all contribute to the hepatocarcinogenic effects of DBC and DiMeDBC.
650    _2
$a financování organizované $7 D005381
650    _2
$a zvířata $7 D000818
650    _2
$a aromatické hydroxylasy $x genetika $7 D001189
650    _2
$a sekvence nukleotidů $7 D001483
650    _2
$a karbazoly $x toxicita $7 D002227
650    _2
$a karcinogeny $x toxicita $7 D002273
650    _2
$a buněčná smrt $x účinky léků $7 D016923
650    _2
$a cytochrom P-450 CYP1A1 $x genetika $7 D019363
650    _2
$a cytochrom P-450 CYP1A2 $x genetika $7 D019388
650    _2
$a DNA primery $7 D017931
650    _2
$a epitelové buňky $x patologie $x účinky léků $7 D004847
650    _2
$a játra $x cytologie $x účinky léků $7 D008099
650    _2
$a metylace $7 D008745
650    _2
$a molekulární struktura $7 D015394
650    _2
$a mutageny $7 D009153
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední F344 $7 D011916
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
700    1_
$a Švihálková Šindlerová, Lenka $7 xx0121174
700    1_
$a Pěnčíková, Kateřina $7 xx0102049
700    1_
$a Krčmář, Pavel $7 xx0137879
700    1_
$a Andrysík, Zdeněk $7 xx0072995
700    1_
$a Chramostová, Kateřina $7 xx0121880
700    1_
$a Marvanová, Soňa. $7 _AN035139
700    1_
$a Valovičová, Zuzana $7 xx0129041
700    1_
$a Kozubík, Alois, $d 1958- $7 mzk2004237023
700    1_
$a Gábelová, Alena $7 xx0118885
700    1_
$a Machala, Miroslav $7 xx0094277
773    0_
$w MED00003430 $t Mutation research. [All sections] $g Roč. 596, č. 1-2 (2006), s. 43-56 $x 0027-5107
910    __
$a ABA008 $b B 1575 $y 9
990    __
$a 20090506084234 $b ABA008
991    __
$a 20111031115319 $b ABA008
999    __
$a ok $b bmc $g 650974 $s 504141
BAS    __
$a 3
BMC    __
$a 2006 $b 596 $c 1-2 $d 43-56 $i 0027-5107 $m Mutation research $x MED00003430
LZP    __
$a 2009-B2/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace